These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9272912)

  • 1. Expression of complement receptors and regulatory proteins on alveolar CD4+ lymphocytes from human immunodeficiency virus-1 infected individuals.
    Aries SP; Schaaf B; Hansen F; Weyrich K; Kurowski V; Dennin R; Dalhoff K
    Eur Respir J; 1997 Aug; 10(8):1736-41. PubMed ID: 9272912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59.
    Schmitz J; Zimmer JP; Kluxen B; Aries S; Bögel M; Gigli I; Schmitz H
    J Clin Invest; 1995 Sep; 96(3):1520-6. PubMed ID: 7544808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic analysis of complement receptor 2+ T lymphocytes: reduced expression on CD4+ cells in HIV-infected persons.
    June RA; Landay AL; Stefanik K; Lint TF; Spear GT
    Immunology; 1992 Jan; 75(1):59-65. PubMed ID: 1371493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of complement receptor 3 (CR3) and regulatory protein CD46 on dendritic cells of antiretroviral naïve and treated HIV-1 infected individuals: Correlation with immune activation status.
    Mishra N; Mohata M; Aggarwal H; Chaudhary O; Das BK; Sinha S; Hazarika A; Luthra K
    Mol Immunol; 2018 Apr; 96():83-87. PubMed ID: 29525453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection.
    Montefiori DC; Cornell RJ; Zhou JY; Zhou JT; Hirsch VM; Johnson PR
    Virology; 1994 Nov; 205(1):82-92. PubMed ID: 7526538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of complement regulatory molecules and other surface markers on neutrophils from synovial fluid and blood of patients with rheumatoid arthritis.
    Jones J; Laffafian I; Cooper AM; Williams BD; Morgan BP
    Br J Rheumatol; 1994 Aug; 33(8):707-12. PubMed ID: 8055195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement and virus-specific antibody-dependent infection of normal B lymphocytes by human immunodeficiency virus type 1.
    Gras G; Richard Y; Roques P; Olivier R; Dormont D
    Blood; 1993 Apr; 81(7):1808-18. PubMed ID: 8461467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines affect resistance of human renal tumour cells to complement-mediated injury.
    Blok VT; Gelderman KA; Tijsma OH; Daha MR; Gorter A
    Scand J Immunol; 2003 Jun; 57(6):591-9. PubMed ID: 12791098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4⁺CD28null T lymphocytes resemble CD8⁺CD28null T lymphocytes in their responses to IL-15 and IL-21 in HIV-infected patients.
    Echeverría A; Moro-García MA; Asensi V; Cartón JA; López-Larrea C; Alonso-Arias R
    J Leukoc Biol; 2015 Sep; 98(3):373-84. PubMed ID: 26034206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion.
    Boyer V; Desgranges C; Trabaud MA; Fischer E; Kazatchkine MD
    J Exp Med; 1991 May; 173(5):1151-8. PubMed ID: 1827139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals.
    Katsikis PD; Wunderlich ES; Smith CA; Herzenberg LA; Herzenberg LA
    J Exp Med; 1995 Jun; 181(6):2029-36. PubMed ID: 7539037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4.
    Thieblemont N; Haeffner-Cavaillon N; Ledur A; L'Age-Stehr J; Ziegler-Heitbrock HW; Kazatchkine MD
    Clin Exp Immunol; 1993 Apr; 92(1):106-13. PubMed ID: 7682158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma and tumour necrosis factor-alpha production by CD4+ T and CD8+ T lymphocytes in AIDS patients with tuberculosis.
    de Castro Cunha RM; Kallas EG; Rodrigues DS; Nascimento Burattini M; Salomao R
    Clin Exp Immunol; 2005 Jun; 140(3):491-7. PubMed ID: 15932510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
    Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
    Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells.
    Moutabarrik A; Nakanishi I; Namiki M; Hara T; Matsumoto M; Ishibashi M; Okuyama A; Zaid D; Seya T
    Lymphokine Cytokine Res; 1993 Jun; 12(3):167-72. PubMed ID: 7688580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction.
    Saifuddin M; Hedayati T; Atkinson JP; Holguin MH; Parker CJ; Spear GT
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1907-11. PubMed ID: 9266986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium.
    Schlesinger LS; Horwitz MA
    J Immunol; 1991 Sep; 147(6):1983-94. PubMed ID: 1679838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adhesion co-receptor expression and intracellular signalling in HIV disease: implications for immunotherapy.
    Ng TT; Guntermann C; Nye KE; Parkin JM; Anderson J; Norman JE; Morrow WJ
    AIDS; 1995 Apr; 9(4):337-43. PubMed ID: 7540845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis.
    Capobianchi MR
    J Biol Regul Homeost Agents; 1996; 10(4):83-91. PubMed ID: 9604776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.